Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced ...

Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

HOUSTON - Moleculin Biotech, Inc. (NASDAQ:MBRX), a pharmaceutical company specializing in treatments for tumors and viruses, has initiated the exercise of existing warrants which is expected to ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc ...

These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and ...

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...

The Chancellor has been warned against another tax raid after forecasts revealed she could be on course for a Budget deficit.

Michael Boyle is an experienced financial professional with more than 10 years working with financial planning, derivatives, equities, fixed income, project management, and analytics. Vikki ...

Fermenta Biotech Limited, Indias leading manufacturer of premium-grade APIs, intermediates, and mixes of vitamins and ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...